Becton, Dickinson and Company (NYSE:BDX) insider Nabil Shabshab sold 6,149 shares of the company’s stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $201.76, for a total transaction of $1,240,622.24. Following the completion of the sale, the insider now directly owns 15,648 shares of the company’s stock, valued at $3,157,140.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Shares of Becton, Dickinson and Company (NYSE:BDX) traded down 0.26% on Wednesday, reaching $200.96. 496,084 shares of the company’s stock traded hands. Becton, Dickinson and Company has a 52 week low of $161.29 and a 52 week high of $206.63. The company has a 50 day moving average price of $199.29 and a 200 day moving average price of $188.36. The firm has a market capitalization of $45.73 billion, a price-to-earnings ratio of 58.20 and a beta of 1.05.

Becton, Dickinson and (NYSE:BDX) last released its earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.44 by $0.02. The firm had revenue of $3.04 billion for the quarter, compared to analysts’ expectations of $3.06 billion. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. Becton, Dickinson and’s quarterly revenue was down 5.1% on a year-over-year basis. During the same quarter last year, the company earned $2.35 EPS. On average, equities research analysts predict that Becton, Dickinson and Company will post $9.46 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 8th will be paid a dividend of $0.73 per share. The ex-dividend date is Thursday, September 7th. This represents a $2.92 annualized dividend and a yield of 1.45%. Becton, Dickinson and’s payout ratio is 83.43%.

TRADEMARK VIOLATION WARNING: “Becton, Dickinson and Company (BDX) Insider Nabil Shabshab Sells 6,149 Shares” was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this report can be read at https://www.watchlistnews.com/becton-dickinson-and-company-bdx-insider-nabil-shabshab-sells-6149-shares/1495605.html.

A number of research analysts have recently issued reports on the stock. Bank of America Corporation reiterated a “buy” rating and set a $225.00 price target (up from $200.00) on shares of Becton, Dickinson and in a research note on Friday, July 21st. BidaskClub upgraded shares of Becton, Dickinson and from a “hold” rating to a “buy” rating in a research note on Monday. Zacks Investment Research upgraded shares of Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $225.00 price target on the stock in a research note on Monday, July 17th. Cowen and Company reiterated a “buy” rating and set a $230.00 price target on shares of Becton, Dickinson and in a research note on Monday. Finally, Barclays PLC reiterated an “equal weight” rating and set a $210.00 price target (up from $205.00) on shares of Becton, Dickinson and in a research note on Thursday, August 10th. One analyst has rated the stock with a sell rating, five have assigned a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. Becton, Dickinson and currently has a consensus rating of “Buy” and a consensus price target of $195.79.

Institutional investors have recently added to or reduced their stakes in the stock. Crestwood Advisors Group LLC bought a new position in Becton, Dickinson and during the first quarter valued at approximately $101,000. North Star Investment Management Corp. boosted its position in Becton, Dickinson and by 3.4% in the first quarter. North Star Investment Management Corp. now owns 549 shares of the medical instruments supplier’s stock valued at $101,000 after buying an additional 18 shares during the last quarter. Almanack Investment Partners LLC. bought a new position in Becton, Dickinson and during the first quarter valued at approximately $105,000. Parkside Financial Bank & Trust boosted its position in Becton, Dickinson and by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 633 shares of the medical instruments supplier’s stock valued at $116,000 after buying an additional 9 shares during the last quarter. Finally, Financial Architects Inc boosted its position in Becton, Dickinson and by 62.7% in the first quarter. Financial Architects Inc now owns 677 shares of the medical instruments supplier’s stock valued at $124,000 after buying an additional 261 shares during the last quarter. 75.57% of the stock is currently owned by hedge funds and other institutional investors.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Insider Buying and Selling by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with Analyst Ratings Network's FREE daily email newsletter.